Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Increasing the levels of a protein called FGF9 can promote hair growth, but humans may not respond the same way due to a lack of certain cells.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Overexpressing the human H-ferritin gene in mice causes mild growth delay and temporary hair loss.

PRP preparation partially activates platelets, causing varied growth factor release.

Sorafenib can cause a unique skin reaction.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Women with PCOS have higher levels of DHEA, IL-6, and TNF-α.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

EGFR inhibitors can cause unusual localized hair growth.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Fibroblast and endothelial cell interactions are crucial in forming hypertrophic scars.

Keratinocytes show more TGF-β system activity and collagen production as they age, which might affect wound scarring.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

TNFα helps grow and maintain liver cells in 3D culture for a long time.

Glyphaea brevis and Monodora myristica can protect against finasteride's harmful effects on blood and oxidative stress in male rats.

Two women had skin reactions from a hair loss treatment and got better after stopping use.

Methadone may worsen liver fibrosis in males with HCV.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Tideglusib may help bone regeneration without being toxic at low doses.

Women with PCOS have more severe liver disease.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.